Premium
Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza
Author(s) -
Ohta Rieko,
Torii Yuka,
Imai Masaki,
Kimura Hiroshi,
Okada Noriko,
Ito Yoshinori
Publication year - 2011
Publication title -
microbiology and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 70
eISSN - 1348-0421
pISSN - 0385-5600
DOI - 10.1111/j.1348-0421.2011.00309.x
Subject(s) - anaphylatoxin , proinflammatory cytokine , complement system , c4a , immunology , influenza a virus , eotaxin , biology , weanling , inflammation , virus , medicine , immune system , chemokine , endocrinology , biochemistry , gene
Anaphylatoxins (C5a, C4a, and C3a) are fragments of activated complement and are leading mediators of the inflammatory response for controlling viral infection. However, an excessive response may increase the severity of infectious diseases. Serum concentrations of proinflammatory mediators, including cytokines, high‐mobility group box 1 and anaphylatoxins, were measured in pediatric 2009 H1N1 influenza patients in order to investigate the pathology of this new influenza. The concentrations of all three anaphylatoxins were significantly enhanced by 2009 H1N1 influenza infection. However, there were no significant differences in anaphylatoxin concentrations between 2009 H1N1 influenza patients with and without severe complications during the early stages of the disease. C3a concentrations dropped significantly during the recovery phase, whereas there were no significant differences between the acute and recovery phases in C5a and C4a concentrations. There was a correlation between C5a and IL‐2. C4a was associated with IL‐1ra, eotaxin, MCP‐1, PDGFbb, and VEGF. C3a was correlated with IL‐2 and IFN‐γ. Taken together, these findings indicate that complement activation occurs in patients infected with 2009 H1N1 influenza virus and demonstrate that anaphylatoxins are involved in increased production of proinflammatory mediators in this new influenza.